Liam Ratcliffe, Director at ARRAY BIOPHARMA INC (ARRY), sold 1,125,728 shares at $6.02 ($6.8M) on 2013-09-26, disclosed to the SEC on 2013-09-30.
Open-market sale of $6.8M ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.02 | 262,207 | $1.6M | 23.4% |
| 2 | $5.99 | 863,521 | $5.2M | 76.6% |
| Total | $6.00 avg | 1,125,728 | $6.8M | 100% |
| Filing → |
| ARVN | SELL | 2021-11-09 | $30.9M | — | Filing → |
| ARVN | BUY | 2020-12-21 | $10.0M | — | Filing → |
| PASG | BUY | 2020-03-13 | $9.9M | — | Filing → |